Cansortium (OTCMKTS:CNTMF) Shares Down 9.1%

Shares of Cansortium Inc. (OTCMKTS:CNTMFGet Rating) traded down 9.1% during trading on Wednesday . The company traded as low as $0.12 and last traded at $0.13. 111,050 shares traded hands during trading, a decline of 6% from the average session volume of 117,983 shares. The stock had previously closed at $0.14.

Analyst Ratings Changes

Separately, BTIG Research assumed coverage on shares of Cansortium in a research note on Friday, October 28th. They set a “buy” rating on the stock.

Cansortium Stock Performance

The business’s 50 day simple moving average is $0.14 and its 200 day simple moving average is $0.16.

Cansortium Company Profile

(Get Rating)

Cansortium, Inc engages in the production and sale of medical cannabis. The firm focuses on oil extracted and derived products for use by medical patients. Its objective is to invest in and develop multiple jurisdictions for the vertical integrated approach for the sale and distribution of processed cannabis oil in medical use frameworks.

Recommended Stories

Receive News & Ratings for Cansortium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cansortium and related companies with's FREE daily email newsletter.